Evaluation of the Clinical Efficacy and Safety of a Spot-on Combination of Imidacloprid 10 % / Moxidectin 2.5 % (Advocate®, Advantage® Multi) in Comparison to an Untreated Control Group in the Treatment of Capillaria boehmi in Naturally Infected Dogs

被引:0
|
作者
Fabrizia Veronesi
Angela Di Cesare
Gabriele Braun
Lisa Günther
Giulia Morganti
Fabrizio Rueca
Gabriele Petry
Roland Schaper
Donato Traversa
机构
[1] University of Perugia,Veterinary Teaching Hospital
[2] University of Teramo,Faculty of Veterinary Medicine
[3] Klifovet AG,undefined
[4] Bayer Animal Health GmbH,undefined
来源
Parasitology Research | 2017年 / 116卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:65 / 74
页数:9
相关论文
共 45 条
  • [1] Evaluation of the Clinical Efficacy and Safety of a Spot-on Combination of Imidacloprid 10 %/Moxidectin 2.5 % (Advocate®, Advantage® Multi) in Comparison to an Untreated Control Group in the Treatment of Capillaria boehmi in Naturally Infected Dogs
    Veronesi, Fabrizia
    Di Cesare, Angela
    Braun, Gabriele
    Guenther, Lisa
    Morganti, Giulia
    Rueca, Fabrizio
    Petry, Gabriele
    Schaper, Roland
    Traversa, Donato
    PARASITOLOGY RESEARCH, 2017, 116 : S65 - S73
  • [2] Evaluation of the Efficacy and Safety of an Imidacloprid 10 % / Moxidectin 1 % Spot-on Formulation (Advocate®, Advantage® Multi) in Cats Naturally Infected with Capillaria aerophila
    Angela Di Cesare
    Fabrizia Veronesi
    Gioia Capelli
    Katrin Deuster
    Roland Schaper
    Fabrizio Solari Basano
    Roberto Nazzari
    Barbara Paoletti
    Donato Traversa
    Parasitology Research, 2017, 116 : 55 - 64
  • [3] Evaluation of the Efficacy and Safety of an Imidacloprid 10 %/Moxidectin 1 % Spot-on Formulation (Advocate®, Advantage® Multi) in Cats Naturally Infected with Capillaria aerophila
    Di Cesare, Angela
    Veronesi, Fabrizia
    Capelli, Gioia
    Deuster, Katrin
    Schaper, Roland
    Basano, Fabrizio Solari
    Nazzari, Roberto
    Paoletti, Barbara
    Traversa, Donato
    PARASITOLOGY RESEARCH, 2017, 116 : S55 - S64
  • [4] Evaluation of the Persistent Preventive Efficacy of 2.5 % Moxidectin/10 % Imidacloprid Spot-on (Advocate®, Advantage® Multi) in Dogs Experimentally Infected with Angiostrongylus vasorum
    Claudia Böhm
    Gabriele Petry
    Holger Schmidt
    Katharina Raue
    Franziska Barthel
    Roland Schaper
    Parasitology Research, 2017, 116 : 1 - 10
  • [5] Evaluation of the Persistent Preventive Efficacy of 2.5 % Moxidectin/ 10 % Imidacloprid Spot-on (Advocate®, Advantage® Multi) in Dogs Experimentally Infected with Angiostrongylus vasorum
    Boehm, Claudia
    Petry, Gabriele
    Schmidt, Holger
    Raue, Katharina
    Barthel, Franziska
    Schaper, Roland
    PARASITOLOGY RESEARCH, 2017, 116 : S1 - S10
  • [6] Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs
    Gabriele Petry
    Marco Genchi
    Holger Schmidt
    Roland Schaper
    Bettina Lawrenz
    Claudio Genchi
    Parasitology Research, 2015, 114 : 131 - 144
  • [7] Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs
    Petry, Gabriele
    Genchi, Marco
    Schmidt, Holger
    Schaper, Roland
    Lawrenz, Bettina
    Genchi, Claudio
    PARASITOLOGY RESEARCH, 2015, 114 : S131 - S144
  • [8] Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi)
    Christophe Le Sueur
    Sophie Bour
    Roland Schaper
    Parasitology Research, 2010, 107 : 1463 - 1469
  • [9] Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi)
    Le Sueur, Christophe
    Bour, Sophie
    Schaper, Roland
    PARASITOLOGY RESEARCH, 2010, 107 (06) : 1463 - 1469
  • [10] Treatment of Naturally Notoedres cati-infested Cats with a Combination of Imidacloprid 10 % / Moxidectin 1 % Spot-on (Advocate® / Advantage® Multi, Bayer)
    Klaus Hellmann
    Gabriele Petry
    Balazs Capari
    Dejan Cvejic
    Friederike Krämer
    Parasitology Research, 2013, 112 : 57 - 66